Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.47 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.47 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.47 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.47 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.47 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.47 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2018495 | 0.85 | CLCN2 (0.47) | GAAMAPTALDH1A1CLCN2HDAC3 | |
| SCHEMBL29580700 | 0.85 | HTT (0.53) | GAAMAPTALDH1A1CLCN2POLB | |
| SCHEMBL15093896 | 0.85 | HTT (0.53) | GAAMAPTALDH1A1CLCN2POLB | |
| SCHEMBL29581227 | 0.85 | MAPT (0.62) | GAAGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL1953684 | 0.85 | MAPT (0.62) | GAAGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL1840339 | 0.85 | GAA (0.45) | GAAKDM4EGRIN2DGRIN3BGRIN1 | |
| SCHEMBL15259641 | 0.84 | ALDH1A1 (0.50) | GAAKDM4EGRIN2DGRIN3BGRIN1 | |
| SCHEMBL8400920 | 0.84 | GRIN2D (0.43) | GAAKDM4EGRIN2DGRIN3BGRIN1 | |
| SCHEMBL3940043 | 0.84 | MAPK1 (0.50) | GAAKDM4EALDH1A1CLCN2POLB | |
| SCHEMBL1955066 | 0.84 | KIF11 (0.39) | GAAKDM4EGRIN2DGRIN3BGRIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3527600-B1 | ISOCYANATE COMPOSITION AND PRODUCTION METHOD FOR ISOCYANATE POLYMER | ASAHI CHEMICAL IND (JP) | 2025-07-09 | — | — | EP | disclosed |
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| CN-118382612-A | Method for producing blocked isocyanate compound and method for producing isocyanate compound | 旭化成株式会社 | 2024-07-23 | — | — | CN | disclosed |
| WO-2023106377-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | 旭化成株式会社 | 2023-06-15 | — | — | WO | disclosed |
| US-20230114799-A1 | ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-04-13 | — | — | US | disclosed |
| US-11548975-B2 | Isocyanate composition and method for producing isocyanate polymer | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-01-10 | — | — | US | disclosed |
| EP-3838892-B1 | METHOD FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2022-10-12 | — | — | EP | disclosed |
| CN-111320562-B | Method for producing isothiocyanate | 旭化成株式会社 | 2022-08-16 | — | — | CN | disclosed |
| CN-111770972-B | Silver nanowire ink and transparent conductive film | 昭和电工株式会社 | 2022-07-01 | — | — | CN | disclosed |
| CN-109803992-B | Isocyanate composition and method for producing isocyanate polymer | 旭化成株式会社 | 2022-05-24 | — | — | CN | disclosed |
| US-20110160476-A1 | N-Substituted Carbamic Acid Ester Production Method and Isocyanate Production Method Using the N-Substituted Carbamic Acid Ester | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-06-30 | — | — | US | disclosed |
| US-20110133121-A1 | N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, And Composition For Transfer And Storage Of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-06-09 | — | — | US | disclosed |
| EP-2322504-A1 | PROCESS FOR THE PREPARATION OF N-SUBSTITUTED CARBAMIC ACID ESTER AND PROCESS FOR THE PREPARATION OF ISOCYANATE USING THE N-SUBSTITUTED CARBAMIC ACID ESTER | Asahi Kasei Chemicals Corporation (JP) | 2011-05-18 | — | — | EP | disclosed |
| US-20100109304-A1 | FIRING AGENT FOR GAS GENERATING DEVICE | NOF CORPORATION (JP) | 2010-05-06 | — | — | US | disclosed |
| EP-1606229-A4 | BINDER MATRIX FOR GAS GENERANTS AND RELATED COMPOSITIONS AND METHODS | AUTOLIV ASP INC (US) | 2008-12-24 | — | — | EP | disclosed |
| US-20080217893-A1 | Firing Agent for Gas Generating Device | NOF CORPORATION (JP) | 2008-09-11 | — | — | US | disclosed |
| EP-1785409-A1 | FIRING AGENT FOR GAS GENERATING DEVICE | NOF CORPORATION (JP) | 2007-05-16 | — | — | EP | disclosed |
| EP-1606229-A2 | BINDER MATRIX FOR GAS GENERANTS AND RELATED COMPOSITIONS AND METHODS | Autoliv ASP, Inc. (US) | 2005-12-21 | — | — | EP | disclosed |
| WO-2005009792-A2 | BINDER MATRIX FOR GAS GENERANTS AND RELATED COMPOSITIONS AND METHODS | AUTOLIV ASP, INC. (US) | 2005-02-03 | — | — | WO | disclosed |
| US-6689236-B1 | MIXTURES OF CELLULOSE ACETATES, DIMETHYL MALONATE, CYCLOGEN OR HEXOGEN FUELS AND N-METHYL-P-NITROANILINE STABILIZERS, FOR USE IN AUTOMOBILE PROTECTIVE DEVICES; AIR BAGS | AUTOLIV ASP, INC. | 2004-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11548975-B2 | Isocyanate composition and method for producing isocyanate polymer | IDH3A, IDH2, IDH3B | GAA 3432/4885KDM4E 297/4885GRIN2D 2664/4885 |
| US-20110133121-A1 | N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, And Composition For Transfer And Storage Of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound | CPS1, ALKBH3, RCC1 | GAA 2933/4885KDM4E 375/4885GRIN2D 3867/4885 |
| US-20110160476-A1 | N-Substituted Carbamic Acid Ester Production Method and Isocyanate Production Method Using the N-Substituted Carbamic Acid Ester | ALKBH3, CPS1, APEH | GAA 1299/4885KDM4E 232/4885GRIN2D 3460/4885 |
| US-20230114799-A1 | ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER | IDH3A, IDH2, IDH3B | GAA 3377/4885KDM4E 392/4885GRIN2D 2677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.